Has James Paci, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,126,342 in general payments to James Paci, MD across 521 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Paci, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Paci, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Paci, MD

Sports Medicine · Woodbury, NYNPI 1316101447

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,786,577 of the $2,126,342 with a category attached, or 84.0%. Arthrex accounts for 98.5% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $538,196, 5.0 times the $108,652 reported in 2019. Among sports medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,126,342in general payments, 2019–2025

Across 521 payments — averaging $4081.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$2.1M
DJO, LLC$11K
Gotham Surgical Solutions & Devices, Inc.$5K
Medacta USA, Inc.$4K
Endo Pharmaceuticals Inc.$3K
Xiros Inc$2K
plus $8K from 19 others

$23,998in research payments, 2019–2025

Across 8 payments — averaging $2999.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Arthrex$24K
Smith+Nephew$350

What the payments were for

Royalty or licence$1,786,57784%
Consulting fees$89,7924%
Speaking & faculty fees$207,15610%
Travel & lodging$25,0441%
Food & beverage$14,9551%
Education$2,8170%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	399	$2,093,890
DJO, LLC	14	$10,522
Gotham Surgical Solutions & Devices, Inc.	16	$4,729
Medacta USA, Inc.	4	$4,145
Endo Pharmaceuticals Inc.	6	$3,416
Xiros Inc	1	$1,750
Miach Orthopaedics, Inc.	2	$1,056
Smith+Nephew	11	$1,014
Arcuro Medical Inc	7	$988
Polaris Technology Solutions LLC	6	$722
Stryker	6	$686
Zimmer Biomet	7	$673
Amgen	12	$458
Bioventus LLC	8	$408
Embody, Inc.	3	$390
Linvatec Corporation	4	$385
Lifenet Health	4	$361
Johnson & Johnson	2	$173
Cartiheal (2009) LTD.	1	$135
Suvon Surgical LLC	1	$125
CGG Medical Inc	1	$110
Medtronic	3	$81
Abanza Inc.	1	$61
Stimwave Technologies Incorporated	1	$50
Triad Life Sciences Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARTHREX$8,240,408
KNEE & HIP INSTRUMENTS REUSABLE INSTRUMENTS GRAFT PREP$113,702
SHOULDER SUTURE FIBERWIRE SUTURETAPE$113,702
AR-7538$97,940
KNEE & HIP IMPLANTS PATELLOFEMORAL OTHER$62,221
KNEE & HIP IMPLANTS PATELLOFEMORAL TENDON REPAIR$32,075
SHOULDER IMPLANTS PUSHLOCKS COMPOSITE ANCHORS$32,075
AR-7538T$26,028
DONJOY$8,232
MECTA$3,400
XIAFLEX$3,230
PROCARE$1,320
SUPERBALL$844
Mecta-C Cervical Cages$700
MAKO$632
TRIATHLON$632
Regeneten$540
AGILI-C$279
LENS 4K$258
Tricera Handpiece$187

How this compares

$2,126,342 in reported general payments places this provider in the 95th percentile of 403 sports medicine providers in New York.

See all sports medicine providers in New York →

Medicare billing

Part B allowed, 2024

$169,802

Medicare patients

263

Services billed

1,930

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Naproxen	87	$449
Meloxicam	14	$19

Paid to pharmacies, not to this prescriber.

Other sports medicine in Woodbury

Steven LeeNyc$3.3M
Gregory DifeliceNew York$1.8M
Ilya VoloshinRochester$786K
Theodore BlaineNew York$765K
Robert MeislinNew York$720K
Danyal NawabiNew York$592K
Stephen NicholasNyc$586K
Riley WilliamsNew York$512K
Bryan KellyNew York$409K
Samuel TaylorNew York$255K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →